Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11246)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2014 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Delitto D, Vertes-George E, Hughes SJ, Behrns KE, Trevino JG. c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8458-8470 [PMID: 25024602 DOI: 10.3748/wjg.v20.i26.8458] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8458.htm |
| Number | Citing Articles |
| 1 |
Sabrina Bimonte, Antonio Barbieri, Maddalena Leongito, Giuseppe Palma, Vitale del Vecchio, Michela Falco, Raffaele Palaia, Vittorio Albino, Mauro Piccirillo, Alfonso Amore, Antonella Petrillo, Vincenza Granata, Francesco Izzo, Hu Li. The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/8352684
|
| 2 |
Tahereh Damghani, Fatemeh Moosavi, Mehdi Khoshneviszadeh, Motahareh Mortazavi, Somayeh Pirhadi, Zahra Kayani, Luciano Saso, Najmeh Edraki, Omidreza Firuzi. Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83069-4
|
| 3 |
Han-xiang Zhan, Jian-wei Xu, Dong Wu, Tai-ping Zhang, San-yuan Hu. Pancreatic cancer stem cells: New insight into a stubborn disease. Cancer Letters 2015; 357(2): 429 doi: 10.1016/j.canlet.2014.12.004
|
| 4 |
Wei Zhou. The long non-coding RNA CCAT1 promotes erlotinib resistance in cholangiocarcinoma by inducing epithelial-mesenchymal transition via the miR-181a-5p/ROCK2 axis. American Journal of Cancer Research 2024; 14(6): 2852 doi: 10.62347/EQDK1844
|
| 5 |
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, Farzad Taghizadeh-Hesary, Masoud Garshasbi, Masoumeh Falah. The genetic landscape and possible therapeutics of neurofibromatosis type 2. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02940-8
|
| 6 |
Zhaohui Chen, Pengbiao Miao, Hongcao Lin, Yanan Lu. AHNAK2 Promotes the Progression of Pancreatic Ductal Adenocarcinoma by Maintaining the Stability of c-MET. Cancer Management and Research 2024; : 431 doi: 10.2147/CMAR.S451486
|
| 7 |
Yueh‐Ming Lin, Chien‐Chang Lu, Yi‐Ping Hsiang, Shu‐Chuan Pi, Chih‐I Chen, Kung‐Chuan Cheng, Hsiao‐Lin Pan, Pei‐Hsuan Chien, Yun‐Ju Chen. c‐Met inhibition is required for the celecoxib‐attenuated stemness property of human colorectal cancer cells. Journal of Cellular Physiology 2019; 234(7): 10336 doi: 10.1002/jcp.27701
|
| 8 |
Teresa Amaral, Tobias Sinnberg, Friedegund Meier, Clemens Krepler, Mitchell Levesque, Heike Niessner, Claus Garbe. The mitogen-activated protein kinase pathway in melanoma part I – Activation and primary resistance mechanisms to BRAF inhibition. European Journal of Cancer 2017; 73: 85 doi: 10.1016/j.ejca.2016.12.010
|
| 9 |
Qi Wu, Ying Tian, Jingqiu Zhang, Hongpeng Zhang, Fengming Gu, Yongdie Lu, Shengnan Zou, Yuji Chen, Pengxiang Sun, Mengyue Xu, Xiaoming Sun, Chao Xia, Hao Chi, A Ying Zhu, Dong Tang, Daorong Wang. Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma. Oncotarget 2017; 8(60): 102721 doi: 10.18632/oncotarget.21970
|
| 10 |
Loan Bui, Qionghua Shen, Tamara Hill, Sayem H Bhuiyan, Rami Barakat, Vanessa Saavedra, Calvin Kong, James D Battiste, Young-tae Kim. Microchannel device for proteomic analysis of migrating cancer cells. Biomedical Physics & Engineering Express 2018; 4(6): 065026 doi: 10.1088/2057-1976/aacd5f
|
| 11 |
Maria Mortoglou, David Wallace, Aleksandra Buha Djordjevic, Vladimir Djordjevic, E. Damla Arisan, Pinar Uysal-Onganer. MicroRNA-Regulated Signaling Pathways: Potential Biomarkers for Pancreatic Ductal Adenocarcinoma. Stresses 2021; 1(1): 30 doi: 10.3390/stresses1010004
|
| 12 |
Giulia M. Stella, Alessandra Gentile, Alice Balderacchi, Federica Meloni, Melissa Milan, Silvia Benvenuti. Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1008-4
|
| 13 |
Cangang Zhang, Yueji Zou, Yanan Zhu, Yi Liu, Hui Feng, Fan Niu, Pengcheng He, Haibo Liu. Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.649326
|
| 14 |
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang, James R Thompson, Raj Kumar Banerjee, Thomas R. Caulfield, Kabir Mody, Yun Yen, Debabrata Mukhopadhyay, Hsu-Shan Huang. Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma. Bioconjugate Chemistry 2019; 30(10): 2703 doi: 10.1021/acs.bioconjchem.9b00632
|
| 15 |
Kshipra S. Karnik, Ishudeep Singh Narula, Aniket P. Sarkate, Pravin S. Wakte. Auto QSAR‐ A Fast Approach for Creation and Application of QSAR Models through Automation. ChemistrySelect 2020; 5(19): 5756 doi: 10.1002/slct.202000744
|
| 16 |
In-Ho Kim, In Hee Lee, Ji Eun Lee, Sook Hee Hong, Tae-Jung Kim, Kyo-Young Lee, Young Kyoon Kim, Seung Joon Kim, Sook Whan Sung, Jae Kil Park, Ie Ryung Yoo, Yeon Sil Kim, Jung-Oh Kim, Jin Hyoung Kang. Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma. Annals of Surgical Oncology 2017; 24(3): 770 doi: 10.1245/s10434-016-5599-z
|
| 17 |
Omidreza Firuzi, Pei Pei Che, Btissame El Hassouni, Mark Buijs, Stefano Coppola, Matthias Löhr, Niccola Funel, Rainer Heuchel, Ilaria Carnevale, Thomas Schmidt, Giulia Mantini, Amir Avan, Luciano Saso, Godefridus J. Peters, Elisa Giovannetti. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells. Cancers 2019; 11(5): 638 doi: 10.3390/cancers11050638
|
| 18 |
Yu-Ze Luan, Chi-Chih Wang, Chia-Ying Yu, Ya-Chuan Chang, Wen-Wei Sung, Ming-Chang Tsai. The Therapeutic Role of NPS-1034 in Pancreatic Ductal Adenocarcinoma as Monotherapy and in Combination with Chemotherapy. International Journal of Molecular Sciences 2024; 25(13): 6919 doi: 10.3390/ijms25136919
|
| 19 |
Dan Wang, Yingjun Zhang, Zhouning Liao, Heming Ge, Cenap Güngör, Yuqiang Li. KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44536-2
|
| 20 |
John W. Wright, Kevin J. Church, Joseph W. Harding. Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer. Current Cancer Drug Targets 2019; 19(10): 782 doi: 10.2174/1568009619666190326130008
|
| 21 |
Xiao-Peng Yang, Shang-Long Liu, Jian-Fei Xu, Shou-Gen Cao, Yu Li, Yan-Bing Zhou. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21. Experimental Cell Research 2017; 357(1): 79 doi: 10.1016/j.yexcr.2017.04.027
|
| 22 |
Yingchao Zhao, Pinan Liu, Na Zhang, Jie Chen, Lukas D. Landegger, Limeng Wu, Fu Zhao, Yanxia Zhao, Yanling Zhang, Jing Zhang, Takeshi Fujita, Anat Stemmer-Rachamimov, Gino B. Ferraro, Hao Liu, Alona Muzikansky, Scott R. Plotkin, Konstantina M. Stankovic, Rakesh K. Jain, Lei Xu. Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proceedings of the National Academy of Sciences 2018; 115(9) doi: 10.1073/pnas.1719966115
|
| 23 |
Diana Spiegelberg, Anja Charlotte Lundgren Mortensen, Kartika Dyah Palupi, Patrick Micke, Julin Wong, Borivoj Vojtesek, David Philip Lane, Marika Nestor. The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01717
|
| 24 |
Jingsheng Yuan, Lulu Tan, Zhijie Yin, Kaixiong Tao, Guobing Wang, Wenjia Shi, Jinbo Gao. Bioinformatics analysis identifies potential chemoresistance‑associated genes across multiple types of cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10533
|
| 25 |
Kevin J. Church, Brett R. Vanderwerff, Rachelle R. Riggers, Beatriz Mateo-Victoriano, Matthew Fagnan, Phillip H. Harris, Jewel C. LeValley, Joseph W. Harding. Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine. Anti-Cancer Drugs 2018; 29(4): 295 doi: 10.1097/CAD.0000000000000598
|
| 26 |
Chen Chen, Binfeng Wu, Mingge Wang, Jinghua Chen, Zhaohui Huang, Jin-Song Shi. GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer. PeerJ 2022; 10: e12728 doi: 10.7717/peerj.12728
|
| 27 |
Jianfei Long, Yu Zhang, Xiang Huang, Junwei Ren, Ping Zhong, Bin Wang. A Review of Drug Therapy in Vestibular Schwannoma. Drug Design, Development and Therapy 2021; : 75 doi: 10.2147/DDDT.S280069
|
| 28 |
Georgina E. Wood, Helen Hockings, Danielle M. Hilton, Stéphanie Kermorgant. The role of MET in chemotherapy resistance. Oncogene 2021; 40(11): 1927 doi: 10.1038/s41388-020-01577-5
|
| 29 |
Yasuyoshi Miyata, Akihiro Asai, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Yasushi Mochizuki, Hideki Sakai. Met in Urological Cancers. Cancers 2014; 6(4): 2387 doi: 10.3390/cancers6042387
|
| 30 |
Soichiro Mori, Hirofumi Akita, Shogo Kobayashi, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Takehiro Noda, Kunihito Gotoh, Yutaka Takeda, Masahiro Tanemura, Yuichiro Doki, Hidetoshi Eguchi. Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer. Cancer Letters 2021; 512: 51 doi: 10.1016/j.canlet.2021.04.029
|
| 31 |
Daniel Delitto, Dongyu Zhang, Song Han, Brian S. Black, Andrea E. Knowlton, Adrian C. Vlada, George A. Sarosi, Kevin E. Behrns, Ryan M. Thomas, Xiaomin Lu, Chen Liu, Thomas J. George, Steven J. Hughes, Shannon M. Wallet, Jose G. Trevino. Nicotine Reduces Survival via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment. Clinical Cancer Research 2016; 22(7): 1787 doi: 10.1158/1078-0432.CCR-15-1256
|
| 32 |
Ingrid Garajová, Elisa Giovannetti, Sara Caponi, Annette van Zweeden, Godefridus J. Peters. MiRNAs and Their Interference with the Main Molecular Mechanisms Responsible for Drug Resistance in Pancreatic Cancer. Current Pharmacology Reports 2015; 1(4): 223 doi: 10.1007/s40495-014-0008-4
|
| 33 |
Haoran Xie, Jingxian Xu, Qiuyan Zhao. Identification of a potential prognostic model combining pyroptosis-related gene with immune microenvironment for pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(19): 17175 doi: 10.1007/s00432-023-05436-0
|
| 34 |
William Berry, Elizabeth Algar, Beena Kumar, Christopher Desmond, Michael Swan, Brendan J. Jenkins, Daniel Croagh. Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity inKRASwild-type tumors. International Journal of Cancer 2017; 140(10): 2331 doi: 10.1002/ijc.30648
|
| 35 |
Mackenzie Goodwin, Ethan V. Abel, Vinee Purohit, Diane M. Simeone. Pancreatic Cancer. 2016; : 1 doi: 10.1007/978-1-4939-6631-8_12-2
|
| 36 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 37 |
Afsane Bahrami, Soodabeh Shahidsales, Majid Khazaei, Majid Ghayour‐Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan. C‐Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives. Journal of Cellular Physiology 2017; 232(10): 2657 doi: 10.1002/jcp.25794
|
| 38 |
María Belén Novoa Díaz, Pedro Carriere, Graciela Gigola, Ariel Osvaldo Zwenger, Natalia Calvo, Claudia Gentili. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide. World Journal of Gastroenterology 2022; 28(26): 3177-3200 doi: 10.3748/wjg.v28.i26.3177
|
| 39 |
Wasia Rizwani, Amanda Allen, Jose Trevino. Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge. Cancers 2015; 7(3): 1785 doi: 10.3390/cancers7030861
|
| 40 |
Mackenzie Goodwin, Ethan V. Abel, Vinee Purohit, Diane M. Simeone. Pancreatic Cancer. 2018; : 349 doi: 10.1007/978-1-4939-7193-0_12
|
| 41 |
Qing-Wen Zhang, Zi-Dan Ye, Lei Shi. c-Met kinase inhibitors: an update patent review (2014-2017). Expert Opinion on Therapeutic Patents 2019; 29(1): 25 doi: 10.1080/13543776.2019.1552261
|
| 42 |
Yujie Li, Ke Zhang, Linjia Peng, Lianyu Chen, Huifeng Gao, Hao Chen. Multiple Perspectives Reveal the Role of DNA Damage Repair Genes in the Molecular Classification and Prognosis of Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(18): 10231 doi: 10.3390/ijms231810231
|
| 43 |
Qing-Wen Zhang, Zi-Dan Ye, Chang Shen, Hong-Xia Tie, Lei Wang, Lei Shi. Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2019; 34(1): 124 doi: 10.1080/14756366.2018.1533822
|
| 44 |
Jia Ma, Tong Cao, Yue Cui, Fan Zhang, Ying Shi, Jun Xia, Z. Peter Wang. miR-223 Regulates Cell Proliferation and Invasion via Targeting PDS5B in Pancreatic Cancer Cells. Molecular Therapy - Nucleic Acids 2019; 14: 583 doi: 10.1016/j.omtn.2019.01.009
|
| 45 |
Chiara Modica, Dora Tortarolo, Paolo M. Comoglio, Cristina Basilico, Elisa Vigna. MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk. International Journal of Molecular Sciences 2018; 19(12): 3920 doi: 10.3390/ijms19123920
|
| 46 |
Nele Van Der Steen, Patrick Pauwels, Ignacio Gil-Bazo, Eduardo Castañon, Luis Raez, Federico Cappuzzo, Christian Rolfo. cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance. Cancers 2015; 7(2): 556 doi: 10.3390/cancers7020556
|
| 47 |
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer. Cancers 2020; 12(5): 1189 doi: 10.3390/cancers12051189
|
| 48 |
Garret Skead, Dhirendra Govender. Gene of the month:MET. Journal of Clinical Pathology 2015; 68(6): 405 doi: 10.1136/jclinpath-2015-203050
|
| 49 |
Lucia D’Amico, Dimas Belisario, Giorgia Migliardi, Cristina Grange, Benedetta Bussolati, Patrizia D’Amelio, Timothy Perera, Ettore Dalmasso, Luca Dalle Carbonare, Laura Godio, Paolo Comoglio, Livio Trusolino, Riccardo Ferracini, Ilaria Roato. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells. Oncotarget 2016; 7(29): 45525 doi: 10.18632/oncotarget.9997
|
| 50 |
Aman Sharma. Chemoresistance in Cancer Cells: Exosomes As Potential Regulators of Therapeutic Tumor Heterogeneity. Nanomedicine 2017; 12(17): 2137 doi: 10.2217/nnm-2017-0184
|
| 51 |
Nicole Lintern, Andrew M. Smith, David G. Jayne, Yazan S. Khaled. Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(16): 4135 doi: 10.3390/cancers15164135
|
| 52 |
Fatemeh Moosavi, Bahareh Hassani, Somayeh Nazari, Luciano Saso, Omidreza Firuzi. Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(6): 189185 doi: 10.1016/j.bbcan.2024.189185
|
| 53 |
Yuying Zhu, He Zhang, Xingxing Han, Zhiyong Wang, Yanfen Cui, Ran Tian, Zhaosong Wang, Baoai Han, Jianfei Tian, Fei Zhang, Ruifang Niu. STAT3 mediated upregulation of C-MET signaling acts as a compensatory survival mechanism upon EGFR family inhibition in chemoresistant breast cancer cells. Cancer Letters 2021; 519: 328 doi: 10.1016/j.canlet.2021.07.048
|
| 54 |
Agnieszka A. Rucki, Kelly Foley, Pingbo Zhang, Qian Xiao, Jennifer Kleponis, Annie A. Wu, Rajni Sharma, Guanglan Mo, Angen Liu, Jennifer Van Eyk, Elizabeth M. Jaffee, Lei Zheng. Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. Cancer Research 2017; 77(1): 41 doi: 10.1158/0008-5472.CAN-16-1383
|
| 55 |
Xin Yang, Hai-Yang Liao, Hai-Hong Zhang. Roles of MET in human cancer. Clinica Chimica Acta 2022; 525: 69 doi: 10.1016/j.cca.2021.12.017
|
| 56 |
Mayank Saraswat, Sakari Joenväärä, Hanna Seppänen, Harri Mustonen, Caj Haglund, Risto Renkonen. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis. Cancer Medicine 2017; 6(7): 1738 doi: 10.1002/cam4.1107
|